DK0460065T3 - Fremgangsmåde til at fremkalde formering af CD4-lymfocytter - Google Patents

Fremgangsmåde til at fremkalde formering af CD4-lymfocytter

Info

Publication number
DK0460065T3
DK0460065T3 DK90904107.1T DK90904107T DK0460065T3 DK 0460065 T3 DK0460065 T3 DK 0460065T3 DK 90904107 T DK90904107 T DK 90904107T DK 0460065 T3 DK0460065 T3 DK 0460065T3
Authority
DK
Denmark
Prior art keywords
lymphocytes
inducing
methyl ester
leucine methyl
alkyl ester
Prior art date
Application number
DK90904107.1T
Other languages
Danish (da)
English (en)
Inventor
Kam Hung Leung
Robert Martin Townsend
Original Assignee
Terumo Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Terumo Corp filed Critical Terumo Corp
Application granted granted Critical
Publication of DK0460065T3 publication Critical patent/DK0460065T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/461—Cellular immunotherapy characterised by the cell type used
    • A61K39/4611—T-cells, e.g. tumor infiltrating lymphocytes [TIL], lymphokine-activated killer cells [LAK] or regulatory T cells [Treg]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/464—Cellular immunotherapy characterised by the antigen targeted or presented
    • A61K39/4643—Vertebrate antigens
    • A61K39/4644—Cancer antigens
    • A61K39/464499—Undefined tumor antigens, e.g. tumor lysate or antigens targeted by cells isolated from tumor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0636—T lymphocytes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20—Cytokines; Chemokines
    • C12N2501/23—Interleukins [IL]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16051—Methods of production or purification of viral material

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK90904107.1T 1989-02-21 1990-02-08 Fremgangsmåde til at fremkalde formering af CD4-lymfocytter DK0460065T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US31342189A 1989-02-21 1989-02-21

Publications (1)

Publication Number Publication Date
DK0460065T3 true DK0460065T3 (da) 1994-09-26

Family

ID=23215624

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90904107.1T DK0460065T3 (da) 1989-02-21 1990-02-08 Fremgangsmåde til at fremkalde formering af CD4-lymfocytter

Country Status (7)

Country Link
EP (1) EP0460065B1 (de)
AT (1) ATE110770T1 (de)
AU (1) AU645488B2 (de)
DE (1) DE69012105T2 (de)
DK (1) DK0460065T3 (de)
HU (1) HU902289D0 (de)
WO (1) WO1990010059A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE68836B1 (en) * 1991-01-16 1996-07-10 Schering Corp Use of interleukin-10 in adoptive immunotherapy of cancer
US5374549A (en) * 1991-01-31 1994-12-20 Terumo Corporation Process of enriching adherent CD4+ T cells from monocyte depleted peripheral blood mononuclear cells with interleukin 2 and interleukin 4
DE4410136A1 (de) * 1993-03-31 1994-10-06 Boehringer Mannheim Gmbh Tumorizide T-Lymphozyten
US5834441A (en) * 1993-09-13 1998-11-10 Rhone-Poulenc Rorer Pharmaceuticals Inc. Adeno-associated viral (AAV) liposomes and methods related thereto
US6652850B1 (en) 1993-09-13 2003-11-25 Aventis Pharmaceuticals Inc. Adeno-associated viral liposomes and their use in transfecting dendritic cells to stimulate specific immunity
EP0797450A4 (de) * 1994-12-01 2000-02-02 New England Deaconess Hospital In vitro t-lymphopoiese system
CN107502589A (zh) * 2017-08-04 2017-12-22 北京世纪劲得生物技术有限公司 一种肿瘤浸润淋巴细胞与单个核细胞共培养方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4849329A (en) * 1986-05-30 1989-07-18 E. I. Du Pont De Nemours And Company Process for preparing lymphokine activated killer cells
SE459008B (sv) * 1986-09-04 1989-05-29 Bioinvent Int Ab Saett att framsstaella humana monoklonala antikroppar
CA1300058C (en) * 1987-01-29 1992-05-05 Joseph D. Irr Process for preparing activated killer cells
US4808151A (en) * 1987-04-27 1989-02-28 E. I. Du Pont De Nemours And Company Simplified method for the preparation of human lymphokine activated killer cells
SE461985B (sv) * 1988-09-13 1990-04-23 Bioinvent Int Ab In vitro immunisering av lymfocytinnehaallande cellpopulationer och materialsats daerfoer

Also Published As

Publication number Publication date
EP0460065B1 (de) 1994-08-31
WO1990010059A1 (en) 1990-09-07
HU902289D0 (en) 1991-11-28
EP0460065A1 (de) 1991-12-11
DE69012105D1 (en) 1994-10-06
ATE110770T1 (de) 1994-09-15
AU5196590A (en) 1990-09-26
AU645488B2 (en) 1994-01-20
DE69012105T2 (de) 1994-12-22

Similar Documents

Publication Publication Date Title
Gillis et al. Biochemical and biologic characterization of lymphocyte regulatory molecules. III. The isolation and phenotypic characterization of Interleukin-2 producing T cell lymphomas.
ATE204019T1 (de) Steigerung der transplantattoleranz durch schwein cytokine
HK1142093A1 (en) Process for the replication of influenza viruses in cell culture, and the influenza viruses obtainable by the process
ATE238410T1 (de) Vorrichtung zur zelltrennung
ATE264717T1 (de) Mikrofluidisches system und verfahren zu dessen betrieb
JPS5598118A (en) Preparation of type-2 interferon and drug containing the same
ES2160236T3 (es) Mejoras en o relacionadas con el procesado de muestras.
HUT64595A (en) Method for producing mammalian cytokine, il-11
DK1604016T3 (da) In vitro-fremgangsmåde til differentiering af monocytiske dendritiske precursorceller i umodne dendritiske celler
DK0460065T3 (da) Fremgangsmåde til at fremkalde formering af CD4-lymfocytter
CA2021500A1 (en) Method for stimulating proliferation of peripheral blood lymphocytes
DE60032508D1 (de) VERFAHREN ZUR VERMEHRUNG VON NATüRLICHEN KILLERZELLEN
Brooks NK cell cloning technology and characteristics of NK cell clones
AU5957090A (en) Enhanced lak cell activation by treatment of human peripheral blood mononuclear cells with amino acid amides
Smith et al. Inhibition of cells in culture by polyamines does not depend on the presence of ruminant serum
EP0483237B1 (de) Schutz zytolytischer aktivität von nk-zellen in peripheren blut-mononuklearzellen
DK1140149T3 (da) Anvendelse af humant væksthormon til forögelse af antallet af cirkulerende CD34+-celler, tilsigtet til genetablering af de hematopoietiske system og immunsystemet fölgende myeloablative eller antibalstiske terapier ved transplantation......
GB8815376D0 (en) Method &/device for separating motile cells from non-motile/less motile cells in mixed cell sample
AU6044090A (en) Preparation of human adherent lymphokine-activated killer (a-lak) cells
EP0257962A3 (de) Verfahren zur Behandlung von Umkreisblut für die Verbesserung der lymphokinaktivierten Töterzell-Immuntherapie
Wagner et al. Heterogeneity of the signal requirements during the primary activation of resting Lyt-2+ cytotoxic T-lymphocyte (CTL) precursors into clonally developing CTL
Lautenschlager et al. Intercellular adhesion molecule 1 (ICAM‐1) induction on hepatocytes is an early marker of acute liver allograft rejection
DK0408742T3 (da) Fremgangsmåde til fremstilling og rensning af hepatitis B vaccine
JJ et al. Optical Tweezers Assessment of WBC Adhesiveness in Myelocytic Leukemia Patients (Microbiorheology)
UA32683A (uk) Спосіб моделювання деформації живих клітин